Clinical outcomes of Epstein-Barr virus infection/reactivation following CAR-T cell therapy: A systematic review.

Transpl ImmunolJul 13, 2026 (epub)
Clinical ResearchOncology (Medical)

Pramod Singh, Ali Shan Hafeez, Asad Zaman et al.

✦ AI-curated · Sources linked

In 30 seconds

This systematic review evaluated the occurrence and outcomes of Epstein-Barr virus (EBV) infection or reactivation in adults undergoing CAR-T therapy. Among 80 patients across five studies, 11 events were identified, indicating a 13.8% occurrence rate. The median time from CAR-T infusion to EBV detection was 9.8 months, with significant morbidity and mortality associated with EBV-related diseases.

Key findings

  • 11 EBV infection/reactivation events were identified among 80 CAR-T recipients, representing 13.8%.
  • 4 patients (36.4%) developed EBV-associated disease, including lymphoproliferative disorders.
  • Confirmed EBV-related mortality occurred in 2 of 11 patients with EBV infection/reactivation.

Why it matters

Understanding the potential complications of EBV infection or reactivation following CAR-T therapy is crucial for clinicians, as it may lead to significant morbidity and mortality, impacting patient management and outcomes.

What to keep in mind

The evidence is limited by small sample sizes, heterogeneous study designs, and inconsistent EBV surveillance practices.

Source

PubMed · PMID 42442615

Published in Transpl Immunol. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Oncology (Medical)

Clinical ResearchPreventive Medicine / Public Health

2025 National Guidelines on the Mediterranean Diet: Executive Summary of a Joint Report by Italian Scientific Societies and the National Institute of Health Task Force on Clinical Practice Guidelines.

This systematic review and practice guideline, developed by a multidisciplinary panel using NUTRIGRADE, assessed Mediterranean diet evidence across nine health domains and one economic domain.

Nutr RevNov 12, 2026Read summary
Clinical ResearchOrthopedic Surgery

Prevention of Venous Thromboembolism after Total Hip or Knee Replacement.

This multicenter randomized comparative-effectiveness noninferiority trial compared 30 days of aspirin, warfarin, or rivaroxaban for VTE prophylaxis after elective total hip or knee arthroplasty.

N Engl J MedNov 12, 2026Read summary
Clinical ResearchAnesthesiology

Effect of discontinuing antihypertensives on perioperative hypotension in older patients before non-cardiac surgery: multicentre, randomised, double blind, controlled trial.

This multicentre, randomised, double blind, placebo controlled trial assessed whether withholding ACE inhibitors or ARBs on the morning of surgery reduces perioperative hypotension in older adults undergoing non-cardiac…

BMJNov 11, 2026Read summary

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text
Create my personalized digestSee plans

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.